From the Departments of Neurology (Drs. Lipton and Bigal), and Epidemiology and Population Health (Dr. Lipton), The Albert Einstein College of Medicine, Bronx, NY; The New England Center for Headache, Stamford, Conn (Dr. Bigal); Janssen Pharmaceuticals, Titusville, NJ (Dr. Amatniek); and the Center for Health Research and Rural Advocacy, Geisinger Health Systems and the Department of Epidemiology, The Johns Hopkins University, Baltimore, Md (Dr. Stewart).
Tools for Diagnosing Migraine and Measuring Its Severity
Version of Record online: 7 MAY 2004
Headache: The Journal of Head and Face Pain
Volume 44, Issue 5, pages 387–398, June 2004
How to Cite
Lipton, R. B., Bigal, M. E., Amatniek, J. C. and Stewart, W. F. (2004), Tools for Diagnosing Migraine and Measuring Its Severity. Headache: The Journal of Head and Face Pain, 44: 387–398. doi: 10.1111/j.1526-4610.2004.04089.x
- Issue online: 7 MAY 2004
- Version of Record online: 7 MAY 2004
- Accepted for publication December 15, 2003.
- diagnostic tools
Migraine remains substantially underdiagnosed and undertreated in the United States. Tools to screen for migraine and to measure headache-related disability can help address barriers to effective diagnosis and treatment. In this article, public health criteria for screening programs for any medical condition are first reviewed. Modifications of these criteria for migraine and other chronic/episodic disorders are then proposed. Migraine is assessed to determine how well it meets criteria for screening and the steps that are necessary before firm public policy recommendations for screening for migraine are possible.